Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Saccharomyces cerevisiae | 6 | 2018 | 206 | 1.570 |
Why?
|
| Saccharomyces cerevisiae Proteins | 9 | 2020 | 118 | 1.220 |
Why?
|
| DNA Repair | 6 | 2024 | 188 | 0.940 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2018 | 44 | 0.930 |
Why?
|
| Doxorubicin | 2 | 2018 | 84 | 0.910 |
Why?
|
| Allyl Compounds | 4 | 2024 | 47 | 0.780 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2020 | 3 | 0.730 |
Why?
|
| Cytotoxins | 1 | 2020 | 11 | 0.720 |
Why?
|
| DNA-Binding Proteins | 7 | 2009 | 539 | 0.720 |
Why?
|
| Aldehydes | 1 | 2018 | 69 | 0.620 |
Why?
|
| Garlic | 3 | 2024 | 30 | 0.500 |
Why?
|
| Sulfides | 3 | 2024 | 62 | 0.480 |
Why?
|
| MutS Homolog 2 Protein | 4 | 2009 | 31 | 0.480 |
Why?
|
| Precancerous Conditions | 2 | 2024 | 82 | 0.440 |
Why?
|
| Manganese | 1 | 2013 | 87 | 0.430 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 803 | 0.420 |
Why?
|
| Adenosine Triphosphatases | 6 | 2009 | 82 | 0.390 |
Why?
|
| Meiosis | 2 | 2009 | 62 | 0.390 |
Why?
|
| DNA Replication | 5 | 2000 | 152 | 0.380 |
Why?
|
| HMGN Proteins | 1 | 2009 | 1 | 0.360 |
Why?
|
| Base Pair Mismatch | 4 | 2009 | 13 | 0.360 |
Why?
|
| DNA Repair Enzymes | 1 | 2009 | 20 | 0.350 |
Why?
|
| DNA Mismatch Repair | 1 | 2009 | 25 | 0.340 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 290 | 0.320 |
Why?
|
| Testis | 1 | 2009 | 187 | 0.310 |
Why?
|
| Genome, Fungal | 1 | 2007 | 22 | 0.310 |
Why?
|
| Carrier Proteins | 1 | 2009 | 305 | 0.290 |
Why?
|
| Proliferating Cell Nuclear Antigen | 5 | 2002 | 43 | 0.290 |
Why?
|
| Breast Neoplasms | 3 | 2024 | 1502 | 0.280 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2007 | 222 | 0.270 |
Why?
|
| Reactive Oxygen Species | 3 | 2024 | 461 | 0.260 |
Why?
|
| Anticarcinogenic Agents | 2 | 2024 | 65 | 0.260 |
Why?
|
| Cadmium | 1 | 2005 | 58 | 0.250 |
Why?
|
| Colorectal Neoplasms | 1 | 2010 | 441 | 0.240 |
Why?
|
| Antifungal Agents | 2 | 2016 | 148 | 0.220 |
Why?
|
| Neoplasms | 2 | 2023 | 1103 | 0.210 |
Why?
|
| Gene Silencing | 2 | 2017 | 151 | 0.210 |
Why?
|
| Epithelial Cells | 2 | 2024 | 384 | 0.200 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2021 | 35 | 0.200 |
Why?
|
| Cell Survival | 3 | 2020 | 864 | 0.200 |
Why?
|
| Phenotype | 4 | 2013 | 689 | 0.190 |
Why?
|
| Fungal Proteins | 2 | 2002 | 140 | 0.190 |
Why?
|
| Language | 1 | 2022 | 157 | 0.190 |
Why?
|
| Humans | 18 | 2024 | 37093 | 0.190 |
Why?
|
| Antioxidants | 3 | 2024 | 416 | 0.180 |
Why?
|
| Breast | 1 | 2021 | 135 | 0.180 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2020 | 50 | 0.180 |
Why?
|
| Recombination, Genetic | 1 | 2000 | 93 | 0.180 |
Why?
|
| Adenosine Triphosphate | 3 | 2017 | 196 | 0.170 |
Why?
|
| Genome | 1 | 2000 | 125 | 0.170 |
Why?
|
| DNA | 3 | 2024 | 574 | 0.170 |
Why?
|
| Frameshift Mutation | 1 | 1998 | 6 | 0.170 |
Why?
|
| Genes, Fungal | 1 | 1998 | 38 | 0.160 |
Why?
|
| Cyclins | 2 | 1995 | 37 | 0.160 |
Why?
|
| RNA Nucleotidyltransferases | 2 | 1996 | 2 | 0.150 |
Why?
|
| Fungi | 2 | 2016 | 89 | 0.150 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2017 | 62 | 0.140 |
Why?
|
| DNA, Fungal | 3 | 2002 | 46 | 0.140 |
Why?
|
| Protein Binding | 4 | 2009 | 972 | 0.140 |
Why?
|
| Lactic Acid | 1 | 2017 | 95 | 0.140 |
Why?
|
| Mutation | 3 | 2013 | 1095 | 0.140 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2015 | 15 | 0.130 |
Why?
|
| Benzoquinones | 1 | 2015 | 36 | 0.130 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 1994 | 4 | 0.120 |
Why?
|
| Disulfides | 1 | 2015 | 77 | 0.120 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1994 | 23 | 0.120 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1994 | 27 | 0.120 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 409 | 0.120 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 85 | 0.120 |
Why?
|
| Quinolinium Compounds | 1 | 2013 | 7 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 169 | 0.110 |
Why?
|
| Microglia | 1 | 2015 | 166 | 0.110 |
Why?
|
| DNA Damage | 3 | 2024 | 352 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 149 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 807 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 356 | 0.110 |
Why?
|
| Magnesium | 1 | 2013 | 97 | 0.110 |
Why?
|
| Alleles | 1 | 2013 | 321 | 0.110 |
Why?
|
| Female | 6 | 2024 | 20969 | 0.110 |
Why?
|
| Nuclear Proteins | 1 | 1994 | 307 | 0.100 |
Why?
|
| Biological Products | 1 | 2013 | 71 | 0.100 |
Why?
|
| Cell Cycle | 3 | 2021 | 326 | 0.100 |
Why?
|
| Benzo(a)pyrene | 2 | 2024 | 126 | 0.100 |
Why?
|
| Cell Nucleus | 1 | 1993 | 366 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 352 | 0.090 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2009 | 18 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 161 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 54 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2009 | 172 | 0.080 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 2231 | 0.080 |
Why?
|
| Genetic Complementation Test | 1 | 2007 | 59 | 0.080 |
Why?
|
| Drug Resistance, Microbial | 1 | 2007 | 26 | 0.080 |
Why?
|
| Cytoprotection | 1 | 2007 | 36 | 0.080 |
Why?
|
| Animals | 5 | 2015 | 15081 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 213 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2009 | 186 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2000 | 1568 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2007 | 120 | 0.070 |
Why?
|
| Base Sequence | 3 | 2001 | 997 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 1996 | 152 | 0.070 |
Why?
|
| Homeodomain Proteins | 2 | 1996 | 132 | 0.070 |
Why?
|
| Sulfhydryl Reagents | 1 | 2005 | 6 | 0.060 |
Why?
|
| Ethylmaleimide | 1 | 2005 | 9 | 0.060 |
Why?
|
| Yeasts | 1 | 2005 | 19 | 0.060 |
Why?
|
| Amino Acids | 1 | 2005 | 145 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2016 | 201 | 0.060 |
Why?
|
| Repressor Proteins | 2 | 1996 | 249 | 0.060 |
Why?
|
| Zinc | 1 | 2005 | 128 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2002 | 188 | 0.060 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2024 | 51 | 0.060 |
Why?
|
| Macromolecular Substances | 2 | 2000 | 96 | 0.060 |
Why?
|
| Mice | 2 | 2015 | 5913 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2000 | 1180 | 0.050 |
Why?
|
| DNA Polymerase beta | 1 | 2021 | 13 | 0.050 |
Why?
|
| Bromodeoxyuridine | 1 | 2021 | 24 | 0.050 |
Why?
|
| Hela Cells | 4 | 1996 | 366 | 0.050 |
Why?
|
| Crossing Over, Genetic | 1 | 2001 | 5 | 0.050 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2001 | 8 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1039 | 0.050 |
Why?
|
| California | 1 | 2023 | 476 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 259 | 0.050 |
Why?
|
| Florida | 1 | 2023 | 410 | 0.050 |
Why?
|
| Consensus Sequence | 1 | 2000 | 24 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 269 | 0.050 |
Why?
|
| Eukaryotic Cells | 1 | 2000 | 36 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2000 | 265 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2015 | 1207 | 0.040 |
Why?
|
| Binding Sites | 1 | 2000 | 651 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 1995 | 55 | 0.040 |
Why?
|
| Simian virus 40 | 2 | 1995 | 47 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2024 | 938 | 0.040 |
Why?
|
| Minority Groups | 1 | 2023 | 596 | 0.040 |
Why?
|
| RNA Helicases | 2 | 1996 | 16 | 0.040 |
Why?
|
| Male | 2 | 2022 | 20025 | 0.040 |
Why?
|
| Glycolysis | 1 | 2017 | 68 | 0.040 |
Why?
|
| Stomach Diseases | 1 | 1996 | 5 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2017 | 161 | 0.030 |
Why?
|
| Cell Nucleolus | 1 | 1996 | 9 | 0.030 |
Why?
|
| Apoptosis | 1 | 2024 | 1398 | 0.030 |
Why?
|
| Opportunistic Infections | 1 | 2016 | 10 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 1996 | 57 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1198 | 0.030 |
Why?
|
| Mycoses | 1 | 2016 | 30 | 0.030 |
Why?
|
| Autoantigens | 1 | 1996 | 81 | 0.030 |
Why?
|
| Anthracenes | 1 | 2015 | 13 | 0.030 |
Why?
|
| Butadienes | 1 | 2015 | 29 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2015 | 19 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 448 | 0.030 |
Why?
|
| Nitrites | 1 | 2015 | 46 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2015 | 31 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 91 | 0.030 |
Why?
|
| Glucose | 1 | 2017 | 230 | 0.030 |
Why?
|
| Nitriles | 1 | 2015 | 69 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 95 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2015 | 115 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 435 | 0.030 |
Why?
|
| DNA Polymerase II | 1 | 1994 | 4 | 0.030 |
Why?
|
| DNA Polymerase III | 1 | 1994 | 10 | 0.030 |
Why?
|
| Cell-Free System | 1 | 1994 | 15 | 0.030 |
Why?
|
| Lysine | 1 | 2015 | 113 | 0.030 |
Why?
|
| Imidazoles | 1 | 2015 | 126 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 116 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 1994 | 31 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 2721 | 0.030 |
Why?
|
| Magnesium Chloride | 1 | 1993 | 3 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 448 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 220 | 0.030 |
Why?
|
| RNA Splicing | 1 | 1993 | 40 | 0.030 |
Why?
|
| Vero Cells | 1 | 2013 | 93 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 201 | 0.030 |
Why?
|
| Biological Transport | 1 | 1993 | 185 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 433 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 1993 | 146 | 0.030 |
Why?
|
| Virus Replication | 1 | 1994 | 278 | 0.030 |
Why?
|
| Drug Design | 1 | 2013 | 162 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 409 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2015 | 928 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2013 | 492 | 0.030 |
Why?
|
| Macrophages | 1 | 2015 | 439 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 602 | 0.020 |
Why?
|
| Bacteria | 1 | 2013 | 255 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1015 | 0.020 |
Why?
|
| DNA Primers | 2 | 2001 | 286 | 0.020 |
Why?
|
| Replication Protein C | 2 | 1996 | 3 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 1996 | 11 | 0.020 |
Why?
|
| Adult | 1 | 2022 | 11712 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 1996 | 191 | 0.020 |
Why?
|
| Kinetics | 2 | 1996 | 708 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 91 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 132 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2001 | 444 | 0.010 |
Why?
|
| Spodoptera | 1 | 1996 | 13 | 0.010 |
Why?
|
| Baculoviridae | 1 | 1996 | 14 | 0.010 |
Why?
|
| Templates, Genetic | 1 | 1996 | 25 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1996 | 52 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 1995 | 4 | 0.010 |
Why?
|
| Histidine | 1 | 1995 | 42 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1996 | 133 | 0.010 |
Why?
|
| Genes, p53 | 1 | 1995 | 25 | 0.010 |
Why?
|
| Transfection | 1 | 1996 | 523 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 325 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 515 | 0.010 |
Why?
|
| Autoantibodies | 1 | 1996 | 103 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1995 | 117 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1995 | 308 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1996 | 578 | 0.010 |
Why?
|
| Cell Line | 1 | 1996 | 1354 | 0.010 |
Why?
|
| Peptides | 1 | 1995 | 320 | 0.010 |
Why?
|